StockData
Silexion Therapeutics Corp logo

Silexion Therapeutics Corp (SLXN) stock

SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.65−0.11 (-6.25%)

Close on Nov 17, 2026Market cap $995.04KP/E –Yield –

Silexion Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Silexion Therapeutics

Silexion Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Silexion Therapeutics figures

See a number that looks wrong?